Elsa: FDA’s New AI Tool Revolutionizing Regulatory Efficiency
The U.S. Food and Drug Administration (FDA) has unveiled Elsa, a generative Artificial Intelligence (AI) tool designed to enhance efficiency across its operations, including scientific reviews, inspections, and regulatory processes. This marks a significant step in modernizing the agency’s workflow and leveraging AI to better serve the American public. Why Did the FDA Develop Elsa? The …